Coriell offers a range of flexible, innovative, and
results-oriented research services that support national and international science. Learn More ›
Genetic variations influence why some people have a greater risk for cancer, or respond poorly to a particular medication. Learn More ›
Induced pluripotent stem cell technology has the ability to revolutionize the way cell biology of human disease is studied. Learn More ›
Lewis L. Coriell, MD, PhD, founded the Institute with a vision of research translating into improved patient care. Learn More ›
Coriell Institute for Medical Research is an independent, non-profit research institute dedicated to the research of human genetic diseases. Learn More ›
-
Welcome to the Coriell Institute for Medical Research
Coriell Institute for Medical Research, founded in 1953 and based in Camden, New Jersey, is an independent non-profit research center dedicated to the study of the human genome. Expert staff and pioneering programs in the fields of personalized medicine, cell biology, cytogenetics, genotyping, and biobanking drive our mission.
The emerging field of personalized medicine draws upon a person’s genomic information to tailor treatments and prescription drug dosing to optimize health outcomes. The Coriell Personalized Medicine Collaborative® (CPMC®) research study is seeking to understand the usefulness of genetic risk and pharmacogenomics in clinical decision-making and healthcare management.
Coriell has a distinguished history in cell biology. We are building upon this expertise by playing an important role in induced pluripotent stem (iPS) cell research. These powerful cells, which can be made from skin cells or blood, are revolutionizing the way human disease is studied and how drugs are developed. The decline of neurons afflicted with Alzheimer’s disease or pancreatic cells fighting diabetes can be studied in a Petri dish. By proving efficacy within the diseased environment prior to clinical trial, drugs can move through the pipeline quicker to reach patients sooner.
In addition to pioneering cutting-edge research initiatives, Coriell offers custom research services – including cell culture, cytogenetic analyses, and molecular biology – to the scientific community. Furthermore, Coriell’s Genotyping and Microarray Center is one of the nation’s largest centers, with high-throughput DNA analysis, CLIA-certified genotyping platforms systems from Illumina and Affymetrix.
Essential to the Institute’s support of international scientific research is the Coriell Biobank. From this renowned cell bank, we manage and distribute the world’s most diverse collection of cell lines, DNA, and other biological resources. The Coriell Biobank provided support to the Human Genome Project, a worldwide program to map the entire human genome, and to the International HapMap Project, a project providing an efficient tool to identify disease-causing genes.
Coriell’s biobanking operation is funded by several National Institutes of Health awards. Our independent research programs rely on private philanthropy from donors like you.
Welcome to Coriell. Come and explore research with us.
In The Spotlight
Coriell In The News
Dr. Christman Delivers 2011 Ullyot Public Affairs Lecture
December 2011 Michael Christman, PhD, delivers lecture exploring the role of genetic information in medical care. Read more ›
Discover Coriell
December 2011 Enjoy the Winter edition of Discover Coriell! Highlights include funding news from The RNR Foundation and The W.W.… Read more ›
Giving to Coriell
Support research at Coriell. Let’s find answers together.
As a non-profit institute, Coriell is fortunate to be engaged in several federally-funded awards. However, we rely on private philanthropy for our more cutting-edge, independent research. Thank you for supporting science!
Meet our Team
Click here to meet our experts.
Coriell scientists are available to speak with you on a variety of topics. Please contact Coriell Communications.
Follow Us
